Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Bevacizumab 12Paclitaxel 11olaparib 10Specimen Handling 10Carboplatin 10Magnetic Resonance Spectroscopy 9liposomal doxorubicin 8Biopsy 5mirvetuximab soravtansine 4Topotecan 4Taxes 4Immunoglobulin G 4Gemcitabine 4Disulfides 4pembrolizumab 3cediranib 3Doxorubicin 3sarilumab 2niraparib 2cemiplimab 2Oxaliplatin 21-dodecylpyridoxal 2tremelimumab 1trastuzumab deruxtecan 1tocilizumab 1sotorasib 1peposertib 1pelcitoclax 1palbociclib 1nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Etodolac × 30 days × Clear all
NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡